Literature DB >> 2383900

Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.

G Hedlund1, M Dohlsten, P A Lando, T Kalland.   

Abstract

Attempts have been made to induce cytolytic T cells to kill target cells that do not express the appropriate target molecules by crosslinking the T cells and the target cells in various ways. One successful strategy has been to use heteroconjugates or bispecific monoclonal antibodies reacting with T cell molecules with activating properties (e.g., mab directed to CD3/TCR) and target cell surface antigens. In this report we show that Staphylococcal enterotoxins (SE) direct human T lymphocytes to execute cytotoxicity toward MHC class II-expressing Raji cells, but not against MHC class II-deficient Raji mutant RJ 2.2.5. Both HLA-DR+ and HLA-DR- effector T lymphocytes are effective in the killing of Raji cells coated with SE. The Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity (SDCC) is a rapid T lymphocyte-mediated cytolytic mechanism killing the targets within an hour of incubation. HLA-DR+ target cells are sensitized to be killed within minutes of incubation with picomolar concentrations of SE. SE-sensitized Raji cells remain targets for SDCC after overnight culture at 37 degrees C, demonstrating that the sensitive state is relatively stable. SEA- and SEB-selective cytolytic T cell lines were established to illustrate the clonal variability of SDCC effectors with respect to SE specificity. We also demonstrate that autologous monocytes and activated T lymphocytes as well as B lymphocytes and freshly prepared HLA-DR+ leukemic cells are excellent targets in SDCC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383900     DOI: 10.1016/0008-8749(90)90218-g

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  17 in total

1.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Authors:  P A Lando; M Dohlsten; G Hedlund; T Brodin; D Sansom; T Kalland
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 3.  Genetically engineered superantigens in experimental tumor therapy.

Authors:  P Antonsson; J Hansson; T Kalland; P A Lando; L Ohlsson; E Schad; A Svensson; M Dohlsten
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.

Authors:  P A Lando; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 5.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

Authors:  M Dohlsten; G Hedlund; E Akerblom; P A Lando; T Kalland
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 8.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

9.  T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.

Authors:  A Sundstedt; S Grundström; M Dohlsten
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

10.  Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.

Authors:  Forough Yousefi; Seyed Davar Siadat; Alireza Azizi Saraji; Saeed Hesaraki; Mohammad Mehdi Aslani; Seyed Fazlollah Mousavi; Abbas Ali Imani Fooladi
Journal:  Tumour Biol       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.